China vs Marshall Islands: Average non-HDL cholesterol levels
China
3.3
in 2018
Marshall Islands
3.3
in 2018
China rank
95th
Marshall Islands rank
95th
Average non-HDL cholesterol levels over time
- China
- Marshall Islands
How they compare
China currently reports 3.3 against 3.3 in Marshall Islands, a difference of 0.
Across all 39 years both countries report, Marshall Islands has been ahead every year.
China ranks 95th and Marshall Islands ranks 95th of 191 countries.
Marshall Islands has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | China | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.88 | 3.71 | 0.83 | Marshall Islands |
| 1990s | 3.06 | 3.74 | 0.68 | Marshall Islands |
| 2000s | 3.2 | 3.59 | 0.39 | Marshall Islands |
| 2010s | 3.3 | 3.4 | 0.1 | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, China or Marshall Islands?
- China, at 3.3 against 3.3 in Marshall Islands as of 2018.
- What is the difference in average non-hdl cholesterol levels between China and Marshall Islands?
- 0, with China ahead.
- How many years of comparable data are there for China and Marshall Islands?
- 39 years are reported by both, from 1980 to 2018.
- How do China and Marshall Islands rank globally for average non-hdl cholesterol levels?
- China ranks 95th and Marshall Islands ranks 95th of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.